Event Brief
Apr 2, 2026 at 7:05 AM ET
Gilead Faces Criticism for HIV Drug Access Denial
By The BriefBrief
Gilead Sciences is under pressure for refusing to sell lenacapavir to MSF, hindering HIV prevention efforts.
WHO: Gilead Sciences
WHAT: Refusal to sell lenacapavir to Médecins Sans Frontières
WHEN: Apr 2, 2026 at 6:51 AM ET
WHERE: USA
WHY: MSF's repeated requests for the drug to aid vulnerable populations.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia
May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21430 of 21430
Same format. Every time.
Continue reading — sign in or create a free account with
